Blog
RSS FeedPosted by Michael Wonder on 22 May 2019
ICER releases draft evidence report on treatments for Duchenne muscular dystrophy
22 May 2019 - Public comment period now open until June 18, 2019; requests to make oral comment during public ...
Posted by Michael Wonder on 22 May 2019
HHS marches forward to enhance drug price transparency
21 May 2019 - HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to ...
Posted by Michael Wonder on 22 May 2019
Agile Therapeutics announces FDA acceptance of the NDA resubmission of Twirla
22 May 2019 - FDA assigns Prescription Drug User Fee Act goal date of 16 November 2019. ...
Posted by Michael Wonder on 22 May 2019
FDA approves Sorilux for adolescent plaque psoriasis
22 May 2019 - Mayne Pharma is pleased to announce that the US FDA has approved Sorilux (calcipotriene) foam, 0.005% ...
Posted by Michael Wonder on 22 May 2019
House Committee proposes 6% increase in FDA funding for FY 2020
22 May 2019 - The House Appropriations Committee on Wednesday released a draft fiscal year 2020 funding bill for the ...
Posted by Michael Wonder on 22 May 2019
U.S. FDA grants priority review of Invokana (canagliflozin) sNDA for the treatment of chronic kidney disease in patients with type 2 diabetes
22 May 2019 - Application was submitted in March 2019 based on landmark phase 3 CREDENCE renal outcomes study published in ...
Posted by Michael Wonder on 22 May 2019
Lilly selling half-price version of popular Humalog insulin
22 May 2019 - A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in ...
Posted by Michael Wonder on 22 May 2019
Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club
23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...
Posted by Michael Wonder on 22 May 2019
Free market activists slam Trump's international drug pricing index
21 May 2019 - Rep. Andy Biggs: 'Seems to me like we're importing drug controls'. ...
Posted by Michael Wonder on 22 May 2019
PolyPid receives a second QIDP designation for D-PLEX100 in abdominal surgery
21 May 2019 - PolyPid Ltd announced today that the United States FDA has granted a second qualified infectious disease product ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: PrEP data
20 May 2019 - PHARMAC responds to a request for information relating to the funding of tenofovir disoproxil fumarate with ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 21 May 2019
Roche’s breast cancer drug gains more insurance benefits
21 May 2019 - The Ministry of Health and Welfare has granted additional reimbursement to Roche’s breast cancer therapy Perjeta (pertuzumab) ...
Posted by Michael Wonder on 21 May 2019
Louisiana is creating a drug price revolution
20 May 2019 - Louisiana is putting the final touches on a revolutionary deal that promises to simultaneously control health ...
Posted by Michael Wonder on 21 May 2019
FDA replaces withdrawn biosimilar guidance with new one on quality-related considerations
21 May 2019 - A week after finalizing guidance on developing interchangeable biosimilars, the US FDA has drafted guidance for ...